During psilocybin-induced ego death, your ordinary sense of self temporarily dissolves. The boundary you normally feel between “you” and everything else thins and can vanish entirely, producing a state where personal identity, autobiographical memory, and the feeling of being a distinct agent in the world all seem to evaporate. Researchers call this experience “ego dissolution,” and neuroimaging studies have traced it to measurable changes in brain connectivity and signaling that disrupt the networks responsible for maintaining your sense of self.
What Ego Dissolution Actually Feels Like
The term “ego death” gets thrown around loosely in psychedelic culture, but the scientific literature has pinned down what it refers to with reasonable precision. The core experience is a feeling that your “self,” “ego,” or “I” is disintegrating, or that the border between you and the external world is dissolving.1PubMed Central. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin People describe losing the sense that they are a separate person observing reality from inside a body. The usual stream of self-referential thoughts (“I want,” “I remember,” “I need to”) quiets or stops. Some people report feeling merged with their surroundings, with other people, or with something they describe as universal consciousness.
Researchers have developed a validated scale specifically for this experience, the Ego-Dissolution Inventory, which captures it through items about losing one’s sense of identity, experiencing unity with the environment, and feeling that the boundaries of the self have become porous. The inventory loads onto a single psychological factor, distinct from its opposite, ego inflation (the grandiose feeling that you are more powerful or important than usual). Ego dissolution also correlates strongly with what psychedelic researchers call “mystical-type” or unitive experiences, the feeling of profound interconnection and sacred meaning.2PubMed Central. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
One finding worth emphasizing: ego dissolution and feelings of connectedness are related but not the same thing. A review of studies found that these two experiences don’t always travel together, meaning you can lose your sense of self without automatically feeling warm interconnection, and vice versa.3Journal of Psychedelic Studies. Being no one, being One: The role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience This distinction matters because popular accounts often treat ego death as if it necessarily comes with a blissful sense of cosmic oneness. For some people it does. For others, losing the self feels more like falling apart than merging with everything.
How Psilocybin Triggers the Experience
Psilocybin itself is actually a prodrug. Your body converts it into psilocin, which is the molecule that crosses the blood-brain barrier and does the heavy lifting. Psilocin’s primary target is the serotonin 2A receptor, and brain imaging has confirmed for the first time that psilocybin intake leads to significant occupancy of these receptors in the human brain. Both the blood levels of psilocin and the degree of receptor occupancy track closely with how intense the subjective experience feels, strongly supporting that stimulating this receptor type is the key driver of the psychedelic state.4PubMed Central. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Serotonin 2A receptors are especially dense in the cortex, the brain’s outer layer responsible for higher-order thinking, perception, and self-awareness. When psilocin floods these receptors, it sets off a cascade of downstream effects in brain circuits that normally keep your perception of reality stable and your sense of self intact.
What Changes in the Brain
Several converging lines of brain research explain why psilocybin can dissolve the sense of self. The changes involve disrupted connectivity in self-related networks, altered filtering of sensory information, and a measurable increase in the brain’s overall unpredictability.
The Default Mode Network Loses Coherence
The default mode network is a set of brain regions that activate when you’re thinking about yourself, remembering your past, imagining your future, or daydreaming. It is essentially the neural infrastructure of the narrative self, the ongoing story you tell about who you are. Under psilocybin, functional connectivity within this network decreases. Ego dissolution specifically correlates with decreased connectivity between the medial temporal lobe (involved in memory) and high-level cortical regions, alongside a breakdown of the salience network, which normally helps you decide what’s important, and reduced communication between the brain’s two hemispheres.1PubMed Central. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin In plain terms, the brain regions that keep your autobiography running and your attention anchored to “me” become disconnected from each other.
The Thalamic Gate Swings Open
Normally, the thalamus acts as a relay station that filters sensory information before it reaches the cortex. It decides, below the level of your awareness, what signals are worth passing through. An established model of psychedelic action proposes that psilocybin impairs this gating function, allowing a flood of sensory and internal body signals to reach cortical regions unchecked.5International Journal of Neuropsychopharmacology. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities Imaging studies have found hyperconnectivity between the thalamus and sensorimotor cortices in the psychedelic state, which correlates with altered visual and auditory perceptions.6PubMed Central. Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States The result is something like a sensory overload of the cortex. When the brain’s filtering mechanism breaks down, the usual hierarchy between self and world becomes harder to maintain.
Brain Entropy Rises
One of the more striking findings in psychedelic neuroscience is that the brain becomes measurably more unpredictable under psilocybin. Researchers use the term “entropy” to describe this: a brain with high entropy has activity patterns that are harder to predict from one moment to the next. Under psilocybin, activity in high-level association networks (the networks involved in abstract thinking and self-reflection) becomes significantly more disorganized compared to baseline. A greater variety of connectivity patterns play out, and the sequence of those patterns is more random.7Frontiers in Human Neuroscience. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs This increase in neural signal diversity has been confirmed across psilocybin, LSD, and ketamine.8Scientific Reports. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Computational modeling suggests that serotonin 2A receptor activation directly causes this entropy increase.9Scientific Reports. A whole-brain model of the neural entropy increase elicited by psychedelic drugs
Think of it this way: your normal waking brain runs in well-worn grooves, repeating familiar patterns of activity. Psilocybin loosens those grooves, making the brain explore states it doesn’t normally visit. The “entropic brain” theory proposes that this is exactly what makes the psychedelic state feel so different from ordinary consciousness, and why the self, which depends on stable, repetitive neural patterns, can fall apart.
Why Some People Experience Bliss and Others Experience Terror
Ego dissolution isn’t one uniform experience. Researchers have identified at least two flavors. One is “oceanic boundlessness,” the positive version, in which losing the self feels expansive, peaceful, and spiritually meaningful. The other is “anxious ego dissolution,” sometimes called “dread of ego dissolution,” in which the experience feels like annihilation, panic, or psychotic fragmentation.
A study using brain imaging and glutamate spectroscopy found that these two flavors have different neurochemical signatures. The strongest predictor of anxious ego dissolution was an increase in glutamate (the brain’s main excitatory neurotransmitter) in the medial prefrontal cortex. The strongest predictor of the positive form of ego dissolution was a decrease in glutamate in the hippocampus.10Neuropsychopharmacology. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin In other words, the same drug can push different brain regions in different directions, and which region’s glutamate changes dominate appears to shape whether you experience ego death as transcendent or terrifying.
This helps explain why “set and setting” matter so much, and why identical doses can produce radically different experiences. The brain doesn’t respond to psilocybin in a vacuum; your psychological state and environment influence which neural pathways light up.
Dose, Timing, and the Arc of the Experience
Ego dissolution is dose-dependent. At low doses (below roughly 15 mg of synthetic psilocybin, equivalent to around one to one-and-a-half grams of dried mushrooms), most people experience perceptual changes, mood shifts, and enhanced introspection without full ego loss. The probability of genuine ego dissolution increases substantially at higher doses. A pharmacokinetic study in healthy participants found that subjective effects were clearly dose-dependent: after 15 mg, average peak effects reached about 58% of the maximum possible intensity, rising to about 73% after 25 mg and about 80% after 30 mg.11PubMed. Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants
The timeline follows a predictable arc. Effects begin roughly 20 to 40 minutes after oral ingestion, as psilocybin is converted to psilocin in the gut and liver. The experience peaks around 60 to 90 minutes in, and this peak is when ego dissolution is most likely to occur. The mean duration of subjective effects ranged from about five-and-a-half to six-and-a-half hours across the doses studied, with higher doses lasting somewhat longer.11PubMed. Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants The most intense period of ego loss typically lasts 30 to 90 minutes within that window, though subjective time perception is profoundly distorted, and minutes can feel like hours.
The Therapeutic Connection
A growing body of research suggests that ego dissolution isn’t just a curiosity but a therapeutically meaningful event. In a study of psilocybin for treatment-resistant depression, the quality of the acute psychedelic experience directly predicted how much people improved. Specifically, higher scores on oceanic boundlessness during the session, and lower scores on dread of ego dissolution, together explained over half the variance in depression improvement at five weeks.12Frontiers in Pharmacology. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression The positive version of self-loss appears to be a key ingredient in lasting therapeutic change.
Some of the most striking findings come from studies of people with life-threatening cancer. High-dose psilocybin produced large decreases in depression and anxiety in cancer patients, along with increases in quality of life, life meaning, and decreases in death anxiety.13PubMed Central. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial A meta-analysis found that psilocybin outperformed placebo for both state and trait anxiety, with benefits lasting at least six months.14PubMed Central. Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis Case studies shed light on why: some patients described feeling as though they experienced their own death during the session and emerged without the fear of it. One patient stated, “I don’t have a fear of death. I am more interested in life now more than ever before.” Another described experiencing her own death twice during the session and coming out viewing death as a beautiful part of existence.15Frontiers in Pharmacology. Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
The logic seems to be that by temporarily experiencing the dissolution of the self, people return with a fundamentally altered relationship to the thing they feared losing. If you’ve already “died” psychologically and come back, the prospect of actual death loses some of its paralyzing grip.
When It Goes Wrong
Ego dissolution under psilocybin can trigger depersonalization and derealization symptoms: the feeling that you are detached from your own body, thoughts, or emotions, or that the world around you is unreal. For the vast majority of people, these symptoms resolve when the drug wears off. But in rare cases, a condition called depersonalization-derealization disorder can persist well beyond the drug’s acute effects. Classic psychedelics, along with cannabis, are among the substances that most frequently precipitate this disorder.16PubMed. Psychedelic-Associated Depersonalization-Derealization Disorder
The risk appears to be highest in people who are psychologically unprepared, who take high doses in uncontrolled settings, or who have a personal or family history of psychotic disorders. The anxious form of ego dissolution, where the loss of self feels like catastrophic disintegration rather than peaceful release, seems to be the on-ramp to these adverse outcomes. This is where the glutamate findings from earlier become clinically relevant: the neurochemical pathways that predict a frightening experience are not the same ones that predict a healing one.
Who Is More Likely to Experience Ego Dissolution
Not everyone who takes a high dose of psilocybin will have a full ego-death experience, and researchers have begun mapping the traits and states that predict what happens. A systematic review of the evidence found that people high in the personality trait of absorption (the tendency to become fully immersed in experiences like music, nature, or daydreaming) and high in openness to experience were more likely to have positive, mystical-type experiences, which overlap heavily with ego dissolution. Critically, a psychological state of surrender, willingness to let the experience unfold without resistance, was also a strong predictor of positive outcomes.17PubMed Central. Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
On the other side, people who were low in openness, or who went into the experience in a preoccupied, apprehensive, or confused state, were more likely to have adverse acute reactions. The participant’s sex did not reliably predict the nature of the experience. Some preliminary biological markers may also play a role: serotonin 2A receptor binding potential, the diversity of connections in executive brain networks, and the volume of certain cortical regions all showed associations with acute responses, though these are early findings.17PubMed Central. Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
Lasting Effects on Personality
One of the more surprising findings in psychedelic research is that a single session with psilocybin can produce lasting shifts in personality. In a controlled study, participants who had a complete mystical experience (which includes ego dissolution) showed significant increases in the personality trait of openness to experience, and these increases persisted over a year later.18PubMed Central. Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness Openness encompasses aesthetic sensitivity, imagination, intellectual curiosity, and tolerance for new ideas. In adults, personality traits are generally considered stable after about age 30, so a single drug experience producing measurable, durable change in a core trait stands out.
Subsequent research on psilocybin therapy for depression found a broader pattern: increases in openness along with trend-level increases in conscientiousness.19PubMed Central. Effects of psilocybin therapy on personality structure A review of this literature also noted decreases in neuroticism and increases in extraversion, which the authors framed as unsurprising given the profound feelings of connection people report during the experience.20PubMed. Ethics and ego dissolution: the case of psilocybin Whether these personality shifts are a direct result of ego dissolution specifically, or of the broader psychedelic experience, remains an open question. But the correlation with mystical-type experiences, which overlap substantially with ego dissolution, suggests that temporarily losing the self may play a central role in the remodeling.
Parallels with Meditation
Experienced meditators have long described states that sound remarkably similar to psychedelic ego dissolution: a fading of the sense of self, dissolution of the subject-object boundary, and a feeling of union with something larger. Researchers have begun testing whether these parallels are more than superficial. A study that combined psilocybin with a mindfulness meditation retreat found that the two practices produced phenomenologically overlapping mystical-type experiences, providing the first experimental evidence that meditation and psilocybin can occasion similar states.21Scientific Reports. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat Population-level data has confirmed neurophysiological and phenomenological overlaps between psychedelic and meditative states, though the research connecting the two is still in its early stages.22PubMed Central. Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States
The comparison is worth paying attention to for a practical reason. Meditation traditions have developed sophisticated frameworks over millennia for navigating the dissolution of self, including how to approach it with equanimity rather than panic. The psychedelic research community is increasingly recognizing that the emphasis on “set” (psychological preparedness) and “setting” (environment and guidance) in psychedelic therapy echoes wisdom traditions that long predated the modern clinical trial. Whether meditation can serve as preparation that makes ego dissolution under psilocybin more likely to be the oceanic rather than the anxious variety is a question researchers are beginning to ask in earnest.
Ego Death Beyond Psilocybin
Ego dissolution is not unique to psilocybin. LSD, DMT, ayahuasca, and mescaline can all produce it, since they share the serotonin 2A receptor mechanism. More surprisingly, ketamine, which operates through an entirely different pharmacological pathway (blocking NMDA glutamate receptors rather than stimulating serotonin receptors), can also induce ego dissolution. Researchers have noted that ego dissolution experiences during ketamine administration are associated with greater antidepressant response, paralleling the pattern seen with psilocybin.1PubMed Central. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin The fact that two pharmacologically unrelated drugs can both dissolve the sense of self and both produce therapeutic benefits when they do suggests that the experience itself, not just the specific drug, may be doing some of the therapeutic work. The increased neural signal diversity that characterizes ego dissolution has been confirmed across psilocybin, LSD, and ketamine alike.8Scientific Reports. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
An evolutionary perspective has proposed that humans have a long relationship with psychedelic compounds, and that the visionary experiences they produce may tap into innate cognitive processes rooted in lower brain systems. According to this view, psychedelics don’t create alien experiences from scratch; they release cognitive functions that are normally suppressed by the prefrontal cortex and default mode network during ordinary waking life.23Frontiers in Neuroscience. The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology Whether or not this hypothesis proves correct, it captures something that many people who have experienced ego death intuitively feel: the dissolved self doesn’t feel like a malfunction. It feels like something underneath ordinary consciousness has been uncovered.